Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) - Equities researchers at Cantor Fitzgerald lowered their FY2025 earnings per share estimates for Nano-X Imaging in a research report issued on Tuesday, April 1st. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings of ($0.71) per share for the year, down from their prior estimate of ($0.61). Cantor Fitzgerald has a "Overweight" rating and a $9.00 price objective on the stock. The consensus estimate for Nano-X Imaging's current full-year earnings is ($0.92) per share.
Separately, D. Boral Capital reaffirmed a "buy" rating and issued a $15.00 target price on shares of Nano-X Imaging in a research report on Monday, March 31st.
Check Out Our Latest Analysis on NNOX
Nano-X Imaging Stock Down 2.9 %
NNOX traded down $0.13 during midday trading on Thursday, hitting $4.28. The company had a trading volume of 482,050 shares, compared to its average volume of 1,729,660. The stock's 50 day moving average price is $6.18 and its 200 day moving average price is $6.58. Nano-X Imaging has a 52 week low of $3.75 and a 52 week high of $11.35. The company has a market capitalization of $247.35 million, a price-to-earnings ratio of -5.01 and a beta of 2.03.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last released its quarterly earnings data on Monday, March 31st. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.08). The company had revenue of $3.00 million during the quarter, compared to the consensus estimate of $3.80 million. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%.
Institutional Trading of Nano-X Imaging
Several hedge funds have recently bought and sold shares of the business. Rhumbline Advisers lifted its stake in shares of Nano-X Imaging by 2.4% in the fourth quarter. Rhumbline Advisers now owns 71,972 shares of the company's stock valued at $518,000 after buying an additional 1,655 shares in the last quarter. US Bancorp DE raised its holdings in shares of Nano-X Imaging by 388.7% in the 4th quarter. US Bancorp DE now owns 3,470 shares of the company's stock worth $25,000 after acquiring an additional 2,760 shares during the last quarter. Tidal Investments LLC lifted its position in Nano-X Imaging by 4.6% in the 3rd quarter. Tidal Investments LLC now owns 64,387 shares of the company's stock valued at $391,000 after acquiring an additional 2,846 shares in the last quarter. SG Americas Securities LLC boosted its stake in Nano-X Imaging by 20.6% during the 4th quarter. SG Americas Securities LLC now owns 24,661 shares of the company's stock valued at $178,000 after purchasing an additional 4,218 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in Nano-X Imaging by 26.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 21,990 shares of the company's stock worth $159,000 after purchasing an additional 4,658 shares in the last quarter. Institutional investors and hedge funds own 21.49% of the company's stock.
About Nano-X Imaging
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Recommended Stories
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
